Suzanne Elvidge has been a freelance writer since 2006, and has spent the last 25 years working in science journalism, publishing, and communications. She writes about pharmaceuticals, consumer healthcare and medicine, and the healthcare, pharmaceutical and biotechnology industries. She has written for a variety of magazines and journals, including Nature Biotechnology, Life Science Leader, New Scientist, Start-Up and Chemistry & Industry, and has authored a number of industry reports and ebooks. She also blogs on a range of topics from PCR, through bioinformatics and big data, to interesting and quirky science facts, books and food, and tweets as @suzannewriter.
Antimicrobial resistance — the ability of previously sensitive microorganisms to resist the effects of an antimicrobial agent — is a growing problem. The World Health Organization has warned that we could be moving into a post-antibiotic era where even minor injuries could lead to life-threatening infections, consequently putting an end to complex surgery and returning us to an era where childbirth is high-risk.
A fellowship programme designed to develop the next generation of senior clinical leaders in health and social care will involve community pharmacy for the first time, it has been announced.
People with type 2 diabetes who take metformin with insulin have a reduced risk of major adverse cardiac events and death compared with those treated with insulin alone, according to a study carried out at Cardiff University and published in PLoS One on 6 May 2016.